Shanghai Junshi Biosciences Co., Ltd.

SEHK:1877 주식 보고서

시가총액: HK$28.0b

Shanghai Junshi Biosciences 관리

관리 기준 확인 3/4

Shanghai Junshi Biosciences CEO는 Cong Li, Nov2021 에 임명되었습니다 의 임기는 7.92 년입니다. 총 연간 보상은 CN¥ 4.22M, 100% 로 구성됩니다. 100% 급여 및 0% 보너스(회사 주식 및 옵션 포함). 는 HK$ 3.61M 가치에 해당하는 회사 주식의 0.013% 직접 소유합니다. 3.61M. 경영진과 이사회의 평균 재임 기간은 각각 3.2 년과 5.4 년입니다.

주요 정보

Cong Li

최고 경영자

CN¥4.2m

총 보상

CEO 급여 비율100.0%
CEO 임기3yrs
CEO 소유권0.01%
경영진 평균 재임 기간3.2yrs
이사회 평균 재임 기간5.4yrs

최근 관리 업데이트

Recent updates

Shanghai Junshi Biosciences Co., Ltd.'s (HKG:1877) Price Is Right But Growth Is Lacking After Shares Rocket 35%

Oct 14
Shanghai Junshi Biosciences Co., Ltd.'s (HKG:1877) Price Is Right But Growth Is Lacking After Shares Rocket 35%

Is Shanghai Junshi Biosciences (HKG:1877) Using Debt Sensibly?

Sep 30
Is Shanghai Junshi Biosciences (HKG:1877) Using Debt Sensibly?

Shanghai Junshi Biosciences Co., Ltd.'s (HKG:1877) Revenues Are Not Doing Enough For Some Investors

Aug 29
Shanghai Junshi Biosciences Co., Ltd.'s (HKG:1877) Revenues Are Not Doing Enough For Some Investors

Shanghai Junshi Biosciences (HKG:1877) Has Debt But No Earnings; Should You Worry?

Jun 28
Shanghai Junshi Biosciences (HKG:1877) Has Debt But No Earnings; Should You Worry?

Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Shares Fly 27% But Investors Aren't Buying For Growth

May 06
Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Shares Fly 27% But Investors Aren't Buying For Growth

Is Shanghai Junshi Biosciences (HKG:1877) Using Debt Sensibly?

Mar 22
Is Shanghai Junshi Biosciences (HKG:1877) Using Debt Sensibly?

Risks Still Elevated At These Prices As Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Shares Dive 29%

Jan 26
Risks Still Elevated At These Prices As Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Shares Dive 29%

Is Shanghai Junshi Biosciences (HKG:1877) A Risky Investment?

Dec 17
Is Shanghai Junshi Biosciences (HKG:1877) A Risky Investment?

Is Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Trading At A 38% Discount?

Nov 20
Is Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Trading At A 38% Discount?

Health Check: How Prudently Does Shanghai Junshi Biosciences (HKG:1877) Use Debt?

Sep 05
Health Check: How Prudently Does Shanghai Junshi Biosciences (HKG:1877) Use Debt?

Revenues Not Telling The Story For Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

May 22
Revenues Not Telling The Story For Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Shares Could Be 35% Below Their Intrinsic Value Estimate

May 01
Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Shares Could Be 35% Below Their Intrinsic Value Estimate

A Look At The Intrinsic Value Of Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

Jan 16
A Look At The Intrinsic Value Of Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

Some Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Analysts Just Made A Major Cut To Next Year's Estimates

Nov 03
Some Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Analysts Just Made A Major Cut To Next Year's Estimates

Is Shanghai Junshi Biosciences (HKG:1877) A Risky Investment?

Oct 12
Is Shanghai Junshi Biosciences (HKG:1877) A Risky Investment?

CEO 보상 분석

Cong Li 의 보수는 Shanghai Junshi Biosciences 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

-CN¥2b

Jun 30 2024n/an/a

-CN¥2b

Mar 31 2024n/an/a

-CN¥2b

Dec 31 2023CN¥4mCN¥4m

-CN¥2b

Sep 30 2023n/an/a

-CN¥2b

Jun 30 2023n/an/a

-CN¥2b

Mar 31 2023n/an/a

-CN¥3b

Dec 31 2022CN¥4mCN¥4m

-CN¥2b

보상 대 시장: Cong 의 총 보상 ($USD 582.84K )은 Hong Kong 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 497.28K ).

보상과 수익: 회사가 수익성이 없는 동안 Cong 의 보상이 증가했습니다.


CEO

Cong Li (60 yo)

3yrs

테뉴어

CN¥4,224,000

보상

Mr. Cong Li has been Co-Chief Executive Officer and Executive Director at Shanghai Junshi Biosciences Co., Ltd. since November 2, 2021 and served as Non-Executive Director since December 22, 2016 until Nov...


리더십 팀

이름위치테뉴어보상소유권
Jun Xiong
Executive Chairman9.7yrsCN¥8.50m13.09%
HK$ 3.7b
Cong Li
Co-CEO & Executive Director3yrsCN¥4.22m0.013%
HK$ 3.6m
Jianjun Zou
GM, CEO & Executive Directorless than a yearCN¥5.86m데이터 없음
Ning Li
Executive Vice-Chairman of the Board6.4yrsCN¥9.93m0.0051%
HK$ 1.4m
Baohong Xu
Financial Director4yrsCN¥2.73m0.00071%
HK$ 198.5k
Zhuobing Zhang
Deputy GM & Executive Directorno dataCN¥8.13m0.88%
HK$ 245.5m
Sheng Yao
Senior VP & Executive Directorno dataCN¥8.01m데이터 없음
Gang Wang
Deputy GM5.3yrsCN¥1.32m0.0010%
HK$ 285.1k
Xin Li
Executive Directorless than a year데이터 없음0.0096%
HK$ 2.7m
Lu Yuan
Assistant to GM & Chief of Internal Audit Department4yrs데이터 없음데이터 없음
Qian Wei
Chief Commercial Officer3.3yrs데이터 없음데이터 없음
Patricia Keegan
Chief Medical Officerno data데이터 없음데이터 없음

3.2yrs

평균 재임 기간

51.5yo

평균 연령

경험이 풍부한 관리: 1877 의 관리팀은 경험 ( 3.2 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Jun Xiong
Executive Chairman9.7yrsCN¥8.50m13.09%
HK$ 3.7b
Cong Li
Co-CEO & Executive Director7.9yrsCN¥4.22m0.013%
HK$ 3.6m
Jianjun Zou
GM, CEO & Executive Director2.4yrsCN¥5.86m데이터 없음
Ning Li
Executive Vice-Chairman of the Board6.4yrsCN¥9.93m0.0051%
HK$ 1.4m
Zhuobing Zhang
Deputy GM & Executive Director7.9yrsCN¥8.13m0.88%
HK$ 245.5m
Sheng Yao
Senior VP & Executive Director7.9yrsCN¥8.01m데이터 없음
Gang Wang
Deputy GM1.1yrsCN¥1.32m0.0010%
HK$ 285.1k
Xin Li
Executive Director1.1yrs데이터 없음0.0096%
HK$ 2.7m
Yi Tang
Non-Executive Director9.5yrs데이터 없음0.74%
HK$ 206.7m
Chun Zhang
Independent Non-Executive Director4.4yrsCN¥200.00k데이터 없음
Xiaoyuan Feng
Independent Non-Executive Director2.9yrsCN¥200.00k데이터 없음
Hongyan Kuang
Chairman of the Board of Supervisorsless than a year데이터 없음데이터 없음

5.4yrs

평균 재임 기간

57yo

평균 연령

경험이 풍부한 이사회: 1877 의 이사회경험(평균 재직 기간 5.4 년)으로 간주됩니다.